GBD Emerging Researcher Award
Created in 2020, the $5,000 award supports emerging global health researchers to carry out innovative research to improve the measurement and knowledge about burden of disease in populations.Congratulations to Dr. Jean Jacques Noubiap, MD, PhD – 2023 winner of the GBD Emerging Researcher Award
Dr. Jean Jacques Noubiap is a specialist physician and scientist from Cameroon whose career has centered around combatting the burden of disease of populations in Africa, with a focus on cardiovascular risk factors and diseases. He is currently a Postdoctoral Scholar in the School of Medicine at the University of California-San Francisco as well as a Global Burden of Disease (GBD) Collaborator and an accomplished author.
Dr. Noubiap was ranked among the top 2% most cited global scientists in 2022, and he has co-authored over 300 publications, with many centered around cardiovascular diseases in Africa. His interest in cardiovascular health is driven by personal past experiences.
Learn more about the award.
Nominations for 2023 are now closed. Please stay tuned for 2024 nominations!
The winner of this award is selected by a committee of distinguished individuals representing different spheres of the GBD Collaborator Network.
Past recipients of the award have continued to make a great impact on public health.
Nomination information
Nominations for 2023 are now closed. Please stay tuned for 2024 nominations!
The GBD Emerging Researcher Award is open to individuals who meet the following criteria:
- An early‐career professional (this may include students pursuing a terminal degree and must be no more than five years post terminal degree)
- Demonstrable evidence that the nominee can carry out Global Burden of Disease (GBD) research(1) of the highest scientific quality, focused on either:
- Methods improvement; or
- Application of GBD methods in low- and middle-income countries (LMIC)(2)
- Preference will be given to candidates who are based in a LMIC. Female nominees are encouraged.
(1) “GBD-related research” defined as research or analysis that fits under the rubric of the Global Burden of Disease Study.
(2) “LMIC” defined by the World Bank as: “For the current 2022 fiscal year, low-income economies are defined as those with a GNI per capita, calculated using the World Bank Atlas method, of $1,045 or less in 2020; lower middle-income economies are those with a GNI per capita between $1,046 and $4,095; upper middle-income economies are those with a GNI per capita between $4,096 and $12,695; high-income economies are those with a GNI per capita of $12,696 or more.”
Please include the following information in the nomination form:
- Nominee’s personal information: title, name, degrees, position or role, organization, nationality, email, phone number, and physical address.
- Nomination letter providing context for the research (1,000 word limit). The nomination letter should:
- Describe the reason for the nomination (i.e., Why this researcher is deserving of the award).
- Describe the nominee’s accomplishments with regard to conducting Global Burden of Disease (GBD) research(1) of the highest scientific quality, focused on either:
- Methods improvement; or
- Application of GBD methods in low- and middle-income countries (LMIC)(2)
- Describe their career to date (to prove eligibility for the award)
- Supporting materials (2 maximum). Please attach additional items that support the nominee’s use of evidence to positively impact health: Piece of published research or completed, unpublished manuscript (for example, a thesis or capstone).
- Curriculum vitae (CV)
- Nominator’s personal information: title, name, degrees, position or role, organization, email, phone number, and physical address.
(1) “GBD-related research” defined as research or analysis that fits under the rubric of the Global Burden of Disease Study.
(2) “LMIC” defined by the World Bank as: “For the current 2022 fiscal year, low-income economies are defined as those with a GNI per capita, calculated using the World Bank Atlas method, of $1,045 or less in 2020; lower middle-income economies are those with a GNI per capita between $1,046 and $4,095; upper middle-income economies are those with a GNI per capita between $4,096 and $12,695; high-income economies are those with a GNI per capita of $12,696 or more.”
Applications will be reviewed by a committee of burden of disease experts, and one winner will be selected.
About the GBD Emerging Researcher Award
In 2018, Professor Christopher Murray, Director of the Institute for Health Metrics and Evaluation (IHME) at the University of Washington was awarded the prestigious John Dirks Canada Gairdner Global Health Award for his pioneering work in establishing and developing the Global Burden of Disease (GBD) study over three decades earlier. Subsequently, the GBD has greatly influenced debates about global health priorities and the development of health services and systems worldwide, and enabled the tracking of progress toward global and national health and development goals.
Professor Murray has donated the proceeds of this award to the University of Washington to establish the GBD Emerging Researcher Award. The primary aim of the award is to support emerging global health researchers to carry out innovative research to improve the measurement and knowledge of burden of disease in populations.
Since 2021, the University of Washington has made one award annually with the winner receiving US$5,000.
Thank you to our promotional partners: University of Washington Population Health Initiative, University of Washington Graduate School, University of Washington School of Public Health, and Cambia Grove.
Contact us
If you have questions about the award, please contact [email protected].